Technical Analysis for ELTP - Elite Pharma Inc

Grade Last Price % Change Price Change
grade B 0.0945 3.85% 0.0035
ELTP closed up 3.85 percent on Friday, December 13, 2019, on 3.33 times normal volume. It was able to find support at its 50 day moving average.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
See historical ELTP trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
50 DMA Support Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Calm After Storm Range Contraction 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Above Upper BB Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Older signals for ELTP ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company which is developing a pipeline of proprietary pharmacological abuse-deterrent opioid products as well as niche generic products. Elite specializes in oral sustained and controlled release drug products which have high barriers to entry. Elite owns generic and OTC products which have been licensed to TAGI Pharma, Epic Pharma and Valeant Pharmaceuticals International. Elite currently has eight commercial products being sold, additional approved products pending manufacturing site transfer and the NDA for SequestOx™, for which it received the CRL from the FDA. Elite’s lead pipeline products include abuse-deterrent opioids which utilize the Company’s patented proprietary technology and a once-daily opioid. These products include sustained release oral formulations of opioids for the treatment of chronic pain. These formulations are intended to address two major limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential opioid abuse. Elite also provides contract manufacturing for Ascend Laboratories (a subsidiary of Alkem Laboratories Ltd.). Elite operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. Learn more at www.elitepharma.com.
Manufacturing RTT Euphoriants Drugs Pharmaceutical Psychoactive Drugs CNX Nifty Fda Chronic Pain Contract Manufacturing Morphinans Heroin Morphine Opioid Alkem Laboratories

Is ELTP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.141
52 Week Low 0.0333
Average Volume 684,447
200-Day Moving Average 0.0791
50-Day Moving Average 0.0864
20-Day Moving Average 0.0866
10-Day Moving Average 0.0863
Average True Range 0.0092
ADX 48.54
+DI 32.5080
-DI 4.2332
Chandelier Exit (Long, 3 ATRs ) 0.0864
Chandelier Exit (Short, 3 ATRs ) 0.1076
Upper Bollinger Band 0.0920
Lower Bollinger Band 0.0812
Percent B (%b) 1.23
BandWidth 12.4711
MACD Line 0.0007
MACD Signal Line 0.0000
MACD Histogram 0.0007
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.1170
Resistance 3 (R3) 0.1163 0.1082 0.1133
Resistance 2 (R2) 0.1082 0.1024 0.1085 0.1120
Resistance 1 (R1) 0.1013 0.0989 0.0973 0.1020 0.1107
Pivot Point 0.0932 0.0932 0.0911 0.0935 0.0932
Support 1 (S1) 0.0863 0.0874 0.0823 0.0870 0.0783
Support 2 (S2) 0.0782 0.0839 0.0785 0.0770
Support 3 (S3) 0.0713 0.0782 0.0758
Support 4 (S4) 0.0720